Table 3.
The expression patterns of SATB2, CK7, CK20 and CDX2 in the different adenocarcinoma in liver needle biopsies.
| CK7 | CK20 and/or CDX2 | Total Cases | SATB2 Positive |
|---|---|---|---|
| Colorectal Cancer | |||
| Positive | Negative | 0 | – |
| Positive | Positive | 9 | 6/9 |
| Negative | Positive | 94 | 89/94 |
| Gastric Cancer | |||
| Positive | Negative | 4 | 0/4 |
| Positive | Positive | 10 | 2/10 |
| Negative | Positive | 3 | 0/3 |
| Pancreatic Cancer | |||
| Positive | Negative | 10 | 0/10 |
| Positive | Positive | 2 | 0/2 |
| Negative | Positive | 0 | – |
| Intrahepatic Cholangiocellular cancer | |||
| Positive | Negative | 24 | 0/24 |
| Positive | Positive | 4 | 0/4 |
| Negative | Positive | 0 | – |
| Lung Cancer | |||
| Positive | Negative | 5 | 1/5 |
| Positive | Positive | 2 | 0/2 |
| Negative | Positive | 0 | – |
| Breast Cancer | |||
| Positive | Negative | 28 | 0/28 |
| Positive | Positive | 0 | – |
| Negative | Positive | 0 | – |